Skip to content
Home/Companies/Biotech/Laigo Bio
Laigo Bio

Laigo Bio

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Laigo Bio?

Laigo Bio is a French Biotech company, currently owned by Angelini Ventures since 2025.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Angelini Ventures
Investor
Angelini Ventures
Angelini Ventures · 2022 · Life Sciences VC

Key facts

HQFrance
SectorBiotech
Websitewww.laigobio.com

More from Angelini Ventures

Other portfolio companies in the same fund.

Epicrispr Biotechnologies
Active
United States· 2026
Handspring Health
Active
HealthTechUS· 2026
Hypervision Surgical
Active
MedTechUK· 2026
MMI (Medical Microinstruments)
Active
MedTechUnited States / Italy· 2026
Adcytherix
Active
BiotechFrance· 2025
Elkedonia
Elkedonia
Active
BiotechFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Laigo Bio?

Laigo Bio is currently owned by Angelini Ventures, through Angelini Ventures, since 2025.

When did Angelini Ventures acquire Laigo Bio?

Angelini Ventures acquired Laigo Bio in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue